Lilly(Eli) & Company

NYSE: LLY
$759.80
-$4.91 (-0.6%)
Real Time Data Delayed 15 Min.

LLY Articles

The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Eli Lilly has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use its rapid-acting insulin and need a lower-cost option.
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
It's an impressive day when two IPOs are well received when drug-selling revenues are unlikely for quite some time, and even longer before profits can be considered.
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Best Buy, Eli Lilly, Hilton, Hyatt, Kraft Heinz, Procter & Gamble and Snap.
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Chipotle Mexican Grill, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre and U.S....
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
The week of March 22, 2019, ended on a very sour note with the markets selling off sharply. That said, there are always some stocks that manage to rise in hard times.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra Energy, Peabody Energy, Teva Pharmaceutical and...
The top analyst upgrades, downgrades and initiations seen on Tuesday included American Electric Power, Apple, Boeing, Coca-Cola, Eli Lilly, RingCentral, Tellurian, Tesla and Vonage.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Judging by the most shorted stocks traded on the New York Stock Exchange between the February 15 and February 28 settlement dates, those sellers were cautious overall, as moves were mixed and...
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.